Comparable stake leader
VANGUARD CAPITAL MANAGEMENT LLC
SEC ownership of AbbVie Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001551152.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
08 May 2026
- Public ticker
- ABBV on NYSE
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
VANGUARD CAPITAL MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
VANGUARD CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
08 May 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001551152
- Issuer location
- North Chicago, IL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of AbbVie Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
08 May 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.5%
13D/G row: VANGUARD CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.5%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
VANGUARD CAPITAL MANAGEMENT LLC
7.5%
Thomas C. Freyman
0.01%
Glenn F. Tilton
0%
Roxanne S. Austin
0%
Frederick H. Waddell
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.5%
|
$28,909,653,374
132,924,058 shares
|
$0 | 31 Mar 2026 |
| Thomas C. Freyman |
3/4/5
Director
|
0.01%
|
$29,102,336
133,810 shares
|
— | 08 May 2026 |
| Glenn F. Tilton |
3/4/5
Director
|
0%
|
$9,043,418
51,914 shares
|
— | 09 May 2025 |
| Roxanne S. Austin |
3/4/5
Director
|
0%
|
$8,607,384
39,576 shares
|
— | 08 May 2026 |
| Frederick H. Waddell |
3/4/5
Director
|
0%
|
$6,541,229
30,076 shares
|
— | 08 May 2026 |
| William H.l. Burnside |
3/4/5
Director
|
0%
|
$6,106,249
28,076 shares
|
— | 08 May 2026 |
| Brett J. Hart |
3/4/5
Director
|
0%
|
$4,478,119
20,590 shares
|
— | 08 May 2026 |
| Melody B. Meyer |
3/4/5
Director
|
0%
|
$3,831,303
17,616 shares
|
— | 08 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$21,791,006.
Buys
$0
Insiders: 0
Sells
$21,791,006
Insiders: 4
Net
-$21,791,006
Shares: -101,944
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 101,944
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 46,279 | $0 | $10,744,698 | -$10,744,698 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 55,665 | $0 | $11,046,308 | -$11,046,308 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 34 reporting-owner rows connected to AbbVie Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
34
Largest Forms 3/4/5 holder
Richard A. Gonzalez
Net 12M change
-$21,791,006
Latest report
01 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Richard A. Gonzalez | Director | $87,456,513 | Mixed | 31 Mar 2025 | ||
| Robert A. Michael | CHAIRMAN OF THE BOARD AND CEO, Director | $49,272,918 | Mixed | 27 Feb 2026 | ||
| Azita Saleki-Gerhardt | Evp, Chief Operations Officer | $47,372,857 | -$8,407,055 | -15% | Mixed | 27 Feb 2026 |
| Laura J. Schumacher | Vice Chairman | $46,597,652 | Mixed | 25 Feb 2022 | ||
| Michael Severino | Vice Chairman | $29,817,686 | Mixed | 23 May 2022 | ||
| Thomas C. Freyman | Director | $29,102,336 | Mixed | 08 May 2026 | ||
| Thomas J. Hudson | Svp, Cso, Global Research | $21,933,260 | Mixed | 28 Feb 2024 | ||
| Jeffrey R. Stewart | Evp, Chief Commercial Officer | $19,601,046 | Mixed | 27 Feb 2026 | ||
| Nicholas J. Donoghoe | Evp, Chief Bus/Strat Officer | $19,465,074 | -$2,639,253 | -12% | Mixed | 27 Feb 2026 |
| Edward J. Rapp | Director | $18,317,807 | Mixed | 01 Jul 2026 | ||
| Gosebruch Henry O | EVP, Chief Strategy Officer | $15,280,302 | Mixed | 16 May 2022 | ||
| Roopal Thakkar | EVP, R&D and CSO | $15,162,255 | Mixed | 27 Feb 2026 | ||
| Scott T. Reents | Evp, Chief Financial Officer | $11,555,937 | Mixed | 27 Feb 2026 | ||
| Glenn F. Tilton | Director | $9,043,418 | Mixed | 09 May 2025 | ||
| Roxanne S. Austin | Director | $8,607,384 | Mixed | 08 May 2026 | ||
| Robert J. Alpern | Director | $8,553,154 | Mixed | 31 Mar 2026 | ||
| Elaine K. Sorg | Svp, Us Commercial Operations | $7,238,029 | Mixed | 25 Apr 2023 | ||
| Frederick H. Waddell | Director | $6,541,229 | Mixed | 08 May 2026 | ||
| William H.l. Burnside | Director | $6,106,249 | Mixed | 08 May 2026 | ||
| Brian L. Durkin | Vp, Controller | $5,128,813 | Mixed | 28 Feb 2023 |
Recent insider transactions for AbbVie Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Edward J. Rapp | ABBV | Stock Equivalent Units | Award | 0.46% | 134 | 29,236 | 30 Jun 2026 | Direct | ||
| Susan E. Quaggin | ABBV | Stock Equivalent Units | Award | 7.84% | 62 | 853 | 30 Jun 2026 | Direct | ||
| Thomas J. Falk | ABBV | Common Stock, $0.01 par value | Award | 92.9% | 1,118 | 2,321 | 08 May 2026 | Direct | ||
| Frederick H. Waddell | ABBV | Common Stock, $0.01 par value | Award | 3.86% | 1,118 | 30,076 | 08 May 2026 | Direct | ||
| Rebecca B. Roberts | ABBV | Common Stock, $0.01 par value | Award | 8.14% | 1,118 | 14,846 | 08 May 2026 | Direct | ||
| Edward J. Rapp | ABBV | Common Stock, $0.01 par value | Award | 2.49% | 1,118 | 45,964 | 08 May 2026 | Direct | ||
| Susan E. Quaggin | ABBV | Common Stock, $0.01 par value | Award | 44.3% | 1,118 | 3,643 | 08 May 2026 | Direct | ||
| Melody B. Meyer | ABBV | Common Stock, $0.01 par value | Award | 6.78% | 1,118 | 17,616 | 08 May 2026 | Direct | ||
| Brett J. Hart | ABBV | Common Stock, $0.01 par value | Award | 5.74% | 1,118 | 20,590 | 08 May 2026 | Direct | ||
| Thomas C. Freyman | ABBV | Common Stock, $0.01 par value | Award | 0.88% | 1,118 | 127,869 | 08 May 2026 | Direct | ||
| Jennifer L. Davis | ABBV | Common Stock, $0.01 par value | Award | 44.3% | 1,118 | 3,643 | 08 May 2026 | Direct | ||
| William H.l. Burnside | ABBV | Common Stock, $0.01 par value | Award | 4.15% | 1,118 | 28,076 | 08 May 2026 | Direct | ||
| Roxanne S. Austin | ABBV | Common Stock, $0.01 par value | Award | 2.91% | 1,118 | 39,576 | 08 May 2026 | Direct | ||
| Susan E. Quaggin | ABBV | Stock Equivalent Units | Award | 9.96% | 71 | 784 | 31 Mar 2026 | Direct | ||
| Edward J. Rapp | ABBV | Stock Equivalent Units | Award | 0.54% | 155 | 28,865 | 31 Mar 2026 | Direct | ||
| Robert J. Alpern | ABBV | Stock Equivalent Units | Award | 0.34% | 35 | 10,369 | 31 Mar 2026 | Direct | ||
| David R. Purdue | ABBV | Common Stock, $0.01 par value | Sale | -66.3% | $1,221,519 | $233.56 | -5,230 | 2,654 | 04 Mar 2026 | Direct |
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Sale | -80.2% | $4,375,549 | $234.39 | -18,668 | 4,619 | 02 Mar 2026 | Direct |
| David R. Purdue | ABBV | Common Stock, $0.01 par value | Tax liability | -19.9% | -2,108 | 8,468 | 27 Feb 2026 | Direct | ||
| Demetris D. Crum | ABBV | Common Stock, $0.01 par value | Tax liability | -16.8% | -1,594 | 7,914 | 27 Feb 2026 | Direct | ||
| Roopal Thakkar | ABBV | Common Stock, $0.01 par value | Tax liability | -13.3% | -8,037 | 52,376 | 27 Feb 2026 | Direct | ||
| Robert A. Michael | ABBV | Common Stock, $0.01 par value | Tax liability | -17% | -36,523 | 178,737 | 27 Feb 2026 | Direct | ||
| Jeffrey R. Stewart | ABBV | Common Stock, $0.01 par value | Tax liability | -22.3% | -23,812 | 83,171 | 27 Feb 2026 | Direct | ||
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Tax liability | -38.9% | -14,850 | 23,287 | 27 Feb 2026 | Direct | ||
| Scott T. Reents | ABBV | Common Stock, $0.01 par value | Tax liability | -35.8% | -21,638 | 38,777 | 27 Feb 2026 | Direct | ||
| Azita Saleki-Gerhardt | ABBV | Common Stock, $0.01 par value | Tax liability | -7.62% | -16,309 | 197,794 | 27 Feb 2026 | Direct | ||
| Nicholas J. Donoghoe | ABBV | Common Stock, $0.01 par value | Tax liability | -14.8% | -12,874 | 74,430 | 27 Feb 2026 | Direct | ||
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Sale | -37% | $5,147,630 | $230.00 | -22,381 | 38,137 | 25 Feb 2026 | Direct |
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Options Exercise | 58.7% | 22,381 | 60,518 | 25 Feb 2026 | Direct | ||
| Perry C. Siatis | ABBV | Option (Right to buy) | Options Exercise | -100% | -22,381 | 0 | 25 Feb 2026 | Direct | ||
| Roopal Thakkar | ABBV | Common Stock, $0.01 par value | Award | 42.9% | 18,137 | 60,413 | 18 Feb 2026 | Direct | ||
| Roopal Thakkar | ABBV | Option (Right to buy) | Award | 21,937 | 21,937 | 18 Feb 2026 | Direct | |||
| David R. Purdue | ABBV | Common Stock, $0.01 par value | Award | 134.8% | 6,071 | 10,576 | 18 Feb 2026 | Direct | ||
| David R. Purdue | ABBV | Option (Right to buy) | Award | 4,875 | 4,875 | 18 Feb 2026 | Direct | |||
| Jeffrey R. Stewart | ABBV | Common Stock, $0.01 par value | Award | 101% | 53,749 | 106,983 | 18 Feb 2026 | Direct | ||
| Jeffrey R. Stewart | ABBV | Option (Right to Buy) | Award | 26,812 | 26,812 | 18 Feb 2026 | Direct | |||
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Award | 725.6% | 33,518 | 38,137 | 18 Feb 2026 | Direct | ||
| Perry C. Siatis | ABBV | Option (Right to buy) | Award | 19,500 | 19,500 | 18 Feb 2026 | Direct | |||
| Azita Saleki-Gerhardt | ABBV | Common Stock, $0.01 par value | Award | 20.8% | 36,811 | 214,103 | 18 Feb 2026 | Direct | ||
| Azita Saleki-Gerhardt | ABBV | Option (Right to Buy) | Award | 20,312 | 20,312 | 18 Feb 2026 | Direct | |||
| Demetris D. Crum | ABBV | Common Stock, $0.01 par value | Award | 34.9% | 2,460 | 9,508 | 18 Feb 2026 | Direct | ||
| Demetris D. Crum | ABBV | Option (Right to buy) | Award | 13,406 | 13,406 | 18 Feb 2026 | Direct | |||
| Nicholas J. Donoghoe | ABBV | Common Stock, $0.01 par value | Award | 49.9% | 29,057 | 87,304 | 18 Feb 2026 | Direct | ||
| Nicholas J. Donoghoe | ABBV | Option (Right to buy) | Award | 20,312 | 20,312 | 18 Feb 2026 | Direct | |||
| Scott T. Reents | ABBV | Common Stock, $0.01 par value | Award | 421.8% | 48,838 | 60,415 | 18 Feb 2026 | Direct | ||
| Scott T. Reents | ABBV | Option (Right to buy) | Award | 21,937 | 21,937 | 18 Feb 2026 | Direct | |||
| Robert A. Michael | ABBV | Common Stock, $0.01 par value | Award | 62.1% | 82,439 | 215,260 | 18 Feb 2026 | Direct | ||
| Robert A. Michael | ABBV | Option (Right to Buy) | Award | 81,251 | 81,251 | 18 Feb 2026 | Direct | |||
| Robert J. Alpern | ABBV | Stock Equivalent Units | Award | 0.33% | 34 | 10,257 | 31 Dec 2025 | Direct | ||
| Susan E. Quaggin | ABBV | Stock Equivalent Units | Award | 10.6% | 68 | 707 | 31 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.